about
Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMAAnti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after StrokeA comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice.Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early InterventionGH Dysfunction in Engrailed-2 Knockout Mice, a Model for Autism Spectrum Disorders.Retracted: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment.Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profilesStroke research at a crossroad: asking the brain for directionsCentral administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice.Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat.Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidencemiR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.Paravertebral fascial massage promotes brain development of neonatal rats via the insulin-like growth factor 1 pathwayThe role of insulin-like growth factor-I in the physiopathology of hearing.Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidityMiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide.Light stimuli control neuronal migration by altering of insulin-like growth factor 1 (IGF-1) signaling.Heat shock response and insulin-associated neurodegeneration.Rescue of neuronal migration deficits in a mouse model of fetal Minamata disease by increasing neuronal Ca2+ spike frequency.Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.Differences in gene expression between strabismic and normal human extraocular muscles.IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsPTSD and DNA Methylation in Select Immune Function Gene Promoter Regions: A Repeated Measures Case-Control Study of U.S. Military Service Members.Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trialNutrition, insulin-like growth factor-1 and retinopathy of prematurityCrosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1.Integrating insulin-like growth factor 1 and sex hormones into neuroprotection: Implications for diabetes.Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression.Proinsulin: from hormonal precursor to neuroprotective factorNew experimental treatments for core social domain in autism spectrum disorders.Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease.Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease.
P2860
Q26772966-2823B194-A366-4D0E-A5E7-FAC3F11799CEQ28072829-A67EC03B-D5F2-4BB8-8BC6-BB7FD91F8AF1Q30495585-34281144-F655-4371-92C3-2DE9A3675CAEQ30640315-31168DEF-9409-4066-8F9B-A51DFD55FDF2Q33581424-F95D6686-F2EE-49F8-9B1E-CE27B54EC044Q33838291-F6E31C46-C192-4D93-B189-0F76FAA0D683Q34113308-87C16A33-98FB-4644-B081-976CB2C111F3Q34173847-209A9413-C176-4535-8243-149899C436ADQ34185639-2CCF4E4F-379F-4052-B408-317EE6BE3DA0Q34227730-D6B73929-3587-48D0-9705-F9F404315C5CQ34611012-3D60F199-3C11-4ECD-AD41-4DBC22881717Q34736776-6CA027B2-2124-4B42-BA84-B494037DFE44Q35099084-19EBF78C-A282-47A3-A728-A54ADC540396Q35100268-64B7B016-6825-4768-812E-F2E67A8BC7BFQ35120182-CFC38828-CFF4-498A-BD3E-CD5B88DF026CQ35135142-9EE0FF8C-8841-47D9-8DC2-C8431AECE594Q35143914-0FC35FF1-203E-4F30-91F8-1ADBB63DBF69Q35625246-89B785F3-149B-4CE8-800F-5776FD431774Q35690505-4A423A4D-4843-4B75-B3BD-19BE191438C6Q35787181-FF7DE0CA-17B8-4F87-9655-169932232DF9Q35870561-B10F390A-209A-405C-8CE6-D78D9A7AB357Q35882476-D8AB90A7-BD82-4A99-AC1B-301E5378EC99Q35947448-7E9B179A-957D-447B-81C7-4E2C91C32D9BQ36132651-EAF0C271-F385-4C41-9C2C-815BED2D4629Q36154585-B97131AA-90A6-4B9F-B1AA-7BF212093CF5Q36516208-BECD1A4F-C919-472E-8D0C-93B665BE33F4Q36578704-8E3C0ACE-DF20-4CF4-BCD0-FC8CD1A6695DQ36948942-9A40D0C7-171C-4654-8EE3-4C648AF4D742Q37151258-DD47E921-9820-4797-B936-701C46018EE2Q37258163-AC259446-1AD5-4C65-AECB-5661AFD52008Q37327417-3D25654A-E597-4B52-ADC7-1CC136FD9762Q37640413-3DD57935-A279-4F06-A95A-F08903B50588Q37658425-BC1E9149-0AFB-4AA5-A863-C94C2167E807Q37688061-1609883C-8DE3-43A6-845C-8E2A72E81A33Q37939111-73193410-1D17-4D5E-9D07-E32A6A14FB50Q38226820-20DC1E3F-95DB-495C-A151-A8D1FC380B59Q42379511-32F5671D-BF42-40B9-AB95-7580ED5056ECQ43617481-031391E4-2889-4B03-BC61-294A79D3C666Q43690639-63D554A0-10FE-4A9C-9E8B-62744A7840A3Q47096119-CAE22570-D79B-4FA9-B9E9-9EABA1B9CEC2
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toward a comprehensive neurobiology of IGF-I.
@ast
Toward a comprehensive neurobiology of IGF-I.
@en
Toward a comprehensive neurobiology of IGF-I.
@nl
type
label
Toward a comprehensive neurobiology of IGF-I.
@ast
Toward a comprehensive neurobiology of IGF-I.
@en
Toward a comprehensive neurobiology of IGF-I.
@nl
prefLabel
Toward a comprehensive neurobiology of IGF-I.
@ast
Toward a comprehensive neurobiology of IGF-I.
@en
Toward a comprehensive neurobiology of IGF-I.
@nl
P2860
P356
P1476
Toward a comprehensive neurobiology of IGF-I.
@en
P2093
Ignacio Torres-Aleman
P2860
P304
P356
10.1002/DNEU.20778
P577
2010-04-01T00:00:00Z